By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Breaking US News – USA Business MediaBreaking US News – USA Business MediaBreaking US News – USA Business Media
  • Home
  • USA
  • World
  • Business
    • CEO
    • Entrepreneur
    • Founder
    • Journalist
    • Realtor
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness Trainer
  • Cryptocurrency
  • Entertainment
  • Technology
Font ResizerAa
Breaking US News – USA Business MediaBreaking US News – USA Business Media
Font ResizerAa
  • Home
  • USA
  • World
  • Business
  • Health
  • Sports
  • Cryptocurrency
  • Entertainment
  • Technology
Search
  • Home
  • USA
  • World
  • Business
    • CEO
    • Entrepreneur
    • Founder
    • Journalist
    • Realtor
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness Trainer
  • Cryptocurrency
  • Entertainment
  • Technology
Follow US
Home » Blog » Reliance Q4 net rises to ₹19,407 cr; revenue beats estimates at ₹2.65 lakh cr
Business

Reliance Q4 net rises to ₹19,407 cr; revenue beats estimates at ₹2.65 lakh cr

Olivia Roberts
By Olivia Roberts
Share
1 Min Read
SHARE

    Reliance Industries reported a net consolidated gain of ₹ 19,407 million rupees for the quarter of March, marking an interannual increase of 2.4%.

Reliance Industries reported a net consolidated gain of ₹ 19,407 million rupees for the quarter of March, marking an interannual increase of 2.4%. | Photo credit: given Ruvic/Reuters

Reliance Industries reported a net consolidated gain of ₹ 19,407 million rupees for the quarter of March, 2.4% more interannual, while revenues increased 10% to ₹ 2.65 Lakh Crore, overcoming estimates.

Topline growth was driven by its dominant oil to chemical business, together with an increase in retail income and digital services.

The company has recommended a dividend of ₹ 5.50 per action and approved the collection of up to ₹ 25000 million rupees through the issuance of non -convertible obligations.

Posted on April 25, 2025

Share This Article
Facebook Copy Link Print

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Apple’s ‘Friday Night Baseball’ is back on March 28 with a World Series documentary in tow

Apple's offered Major League Baseball games through the Apple TV app since…

10 Benefits of Forex Hedging Most Traders Don’t Know About

Hedging is possibly the most misunderstood trading method in the world. It's…

Understanding the Bitcoin Halving Cycle and Its Impact on 2025 Market Trends

In the realm of cryptocurrency, the bitcoin halving cycle is one of…

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.
Sign Up for Free

You Might Also Like

Business

Stock Market Live Updates 22 April 2025: Stock to buy today: KFin Technologies (₹1,200.55) – BUY

By Olivia Roberts
Business

 TCS, Infosys, Wipro witness 15% QoQ uptick in deal win size, led by smaller deals

By Olivia Roberts
Business

From Curly Hair Kid to Industry Trailblazer: The Jennifer Janisch Story

By Olivia Roberts
Business

Rupee recovers on RBI intervention, rises 17 paise to close at 85.41 against US dollar

By Olivia Roberts
Breaking US News – USA Business Media
USA
  • USA
  • World
  • Technology
  • Cryptocurrency
Business
  • CEO
  • Founder
  • Journalist
  • Entrepreneur
  • Technology
Health
  • Doctor
  • Beauty Cosmetics
  • Plastic Surgeon
Sports
  • Coach
  • Fitness Trainer
  • Entertainment

© 2017-2026 usabusinessmedia. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?